https://www.corsalex.com/home daily 1.0 2025-11-11 https://images.squarespace-cdn.com/content/v1/628c2715f4fef83526a777fc/1656605813884-XHV29RAYUIBOO1SOHFWL/unsplash-image-OgvqXGL7XO4.jpg Home - License promising technologies. Corsalex is actively looking to in-license promising technologies to advance into the clinic and through approval. We focus on disease modifying therapies that have a strong scientific rationale. https://images.squarespace-cdn.com/content/v1/628c2715f4fef83526a777fc/1657055475060-UO7Q67YBVU038E9GLLRW/unsplash-image-IHfOpAzzjHM.jpg Home - Fund early-stage research. Whether it is early work to better understand the pathology of c9orf72 ALS/FTD, or translational work to bridge the gap between early findings and a drug candidate, Corsalex seeks to fund work in academic labs that can advance our understanding and treatment of this disease. https://images.squarespace-cdn.com/content/v1/628c2715f4fef83526a777fc/1656605991853-2TY2NR77T2M8UW04F7HP/unsplash-image-l5Tzv1alcps.jpg Home - Partner with industry. The landscape for treating CNS diseases is changing rapidly. To capitalize on these exciting developments, Corsalex is looking for collaborations with industry partners in a way that can spur C9-specific therapies. https://images.squarespace-cdn.com/content/v1/628c2715f4fef83526a777fc/1657055522200-A9VIQQANJ3R4SSG960RF/unsplash-image-BxXgTQEw1M4.jpg Home - Work with patient advocacy groups. Our ultimate goal is to help patients and families with this devastating disease. To that end, we seek to partner with patient advocacy groups to help improve patients’ lives. https://www.corsalex.com/contact daily 0.75 2025-11-04 https://www.corsalex.com/current-programs daily 0.75 2022-07-11 https://www.corsalex.com/team daily 0.75 2025-01-27 https://images.squarespace-cdn.com/content/v1/628c2715f4fef83526a777fc/70b3b4a9-2899-4c94-a95c-63bbd5832722/Jim+headshot.png Team - James W. Larrick, MD, PhD Dr. James Larrick is a biomedical entrepreneur with an international reputation in biotechnology. He has developed expertise in cytokines, therapeutic antibodies, molecular biology, and pharmaceutical drug development over his thirty-five-year career, and he has written or co-authored nine books, published over 300 papers/chapters, and submitted more than fifty patents. Dr. Larrick earned his M.D. and Ph.D. from Duke University as a graduate of the prestigious Medical Scientist Training Program. After completing his medical house-staff training at Stanford University, Dr. Larrick contributed to the development of the first therapeutic human monoclonal antibodies for cancer and infectious diseases as a postdoctoral research fellow in the Stanford Cancer Biology Research Labs. https://images.squarespace-cdn.com/content/v1/628c2715f4fef83526a777fc/245ffd52-50fe-479c-98bc-b739f60a00e5/BTS-201_smiling.jpg Team - Piero H. Mendez Tobias Keene, D.D.S. Hailing from Richmond, Virginia, Dr. Tobias Keene brings a bit of unabashed Southern hospitality to all his patients. He moved to Washington, D.C. over thirty years ago as a freshman at Ivy College. Right after graduation, he attended World University’s School of Dentistry. Before opening Keene Dental in 1994, he worked for free clinics and some of the finest practices in the District. He is part of the 123 Dental Association and stays up-to-date on the latest dental discoveries. When not striving to keep his patients happy and healthy, he’s enjoys hiking with his family in Rock Creek Park. https://images.squarespace-cdn.com/content/v1/628c2715f4fef83526a777fc/321eeeaa-5c85-4ba3-b492-8a93aa0243ee/Andy.jpg Team - Andrew R. Mendelsohn, PhD Dr. Mendelsohn holds a B.A in Biophysics and Natural Science from the University of Pennsylvania, a PhD in Molecular, Cell biology and Biochemistry from Brown University, performed postdoctoral training at Harvard Medical School and previously was a Research Fellow at Nobel Laureate Sydney Brenner’s innovative organization, Molecular Sciences Institute, which sought to integrate computational and molecular biology. https://images.squarespace-cdn.com/content/v1/628c2715f4fef83526a777fc/1155d872-d35c-4f56-978f-c8244cd1c0a5/Keren.jpeg Team - Keren Ziv, PhD Dr. Keren Ziv received a PhD from the Weizmann Institute of Science Israel, in the field of cancer angiogenesis and MRI reporter genes. She pursued a postdoctoral fellowship at Stanford, where she conducted research in the field of regenerative medicine and heart diseases in the Molecular Imaging Program (MIPS). Keren has experience in both drug and medical device development. Among her former roles, she was a senior director at X37, a biotech company using AI for rapid drug discovery, the head of strategic innovation at LevitasBio, a company applying magnet ic levitation technology for cellular analysis, the CSO of CytoMag, developing microfluidic systems for rapid cell isolation, and served as a fellow of Life Science Angels (LSA), medical device and BIO screening committees. Keren is a board member of the Coulter program at University of Virginia, a translational research program with a mission to support, develop and validate translational research projects that can be widely adopted. https://www.corsalex.com/patient-resources daily 0.75 2025-10-30 https://images.squarespace-cdn.com/content/v1/628c2715f4fef83526a777fc/1659632174858-PGRHTAZ77WYNLM2LHAFB/ALS_tdi.jpg Patient Resources https://images.squarespace-cdn.com/content/v1/628c2715f4fef83526a777fc/1659718616985-16959L7DO75J494D4D9X/AFTD+Logo.png Patient Resources https://images.squarespace-cdn.com/content/v1/628c2715f4fef83526a777fc/1659719316509-6E4HF4O11LWCOTI59FA6/Target+ALS+Logo.png Patient Resources https://images.squarespace-cdn.com/content/v1/628c2715f4fef83526a777fc/1659721969930-8790HW989U7AP16PI148/EALS.jpg Patient Resources https://images.squarespace-cdn.com/content/v1/628c2715f4fef83526a777fc/1659722100243-IW8XJRBSHIZLPCPWM0E7/ALSASS.jpeg Patient Resources https://images.squarespace-cdn.com/content/v1/628c2715f4fef83526a777fc/1659980063577-6C3JDEUFB93Y6T8YUQQS/FTD_logo2.jpg Patient Resources https://images.squarespace-cdn.com/content/v1/628c2715f4fef83526a777fc/1659980196176-LFI606X98JIAN83PKJR9/NEALS+.jpeg Patient Resources https://images.squarespace-cdn.com/content/v1/628c2715f4fef83526a777fc/16341061-5734-4aec-b86a-3b140b3827bb/GENFI1.jpg Patient Resources https://images.squarespace-cdn.com/content/v1/628c2715f4fef83526a777fc/d769ee8e-72db-4b10-a1cc-e4caceef5bd0/_1Talk+FTD+Logo.png Patient Resources https://images.squarespace-cdn.com/content/v1/628c2715f4fef83526a777fc/6f91f5e0-8d90-48e8-9e5b-e3105091e8de/ALSNetwork_BrandFiles_Stacked_Teal%26DarkTeal.png Patient Resources https://www.corsalex.com/careers daily 0.75 2024-09-24 https://images.squarespace-cdn.com/content/v1/628c2715f4fef83526a777fc/1722982996677-FJZBG6P05AMOP0VIH1FI/unsplash-image-pwcKF7L4-no.jpg https://www.corsalex.com/scientist-role daily 0.75 2024-08-06 https://www.corsalex.com/collaboration daily 0.75 2024-09-30 https://images.squarespace-cdn.com/content/v1/5ec321c2af33de48734cc929/1618497259178-6XJGK9GR6YAVBQL5L519/20140301_Trade-151_012-2.jpg Collaborations https://images.squarespace-cdn.com/content/v1/5ec321c2af33de48734cc929/1607694583486-2PQT0LQ193RL7MCB6DX4/20140228_Trade+151_0046.jpg Collaborations https://images.squarespace-cdn.com/content/v1/5ec321c2af33de48734cc929/1607694644871-IC85FNH781UNZSZEGHDR/Aro+Ha_0428.jpg Collaborations https://images.squarespace-cdn.com/content/v1/5ec321c2af33de48734cc929/1589847903854-US92D97SPXSFKLOB824X/image-asset.jpeg https://images.squarespace-cdn.com/content/v1/5ec321c2af33de48734cc929/1589847904056-0T9RWJ5K3RJ19LDYKWHZ/image-asset.jpeg https://www.corsalex.com/corsalex-fellowship daily 0.75 2026-02-02 https://www.corsalex.com/corsalex-fellowship-1 daily 0.75 2025-10-23